1, 2% af 1. 029 patienter behandlet med Enbrel, sammenlignet med 1, 5% af 460 patienter behandlet med placebo.
Among patients with plaque psoriasis treated in placebo-controlled trials, the frequency of serious adverse events was about 1.2% of 1,029 patients treated with Enbrel compared with 1.5% of 460 placebo-treated patients.